Skip to content
Menu
Search
Search for:
Search
Technologies and services
Technologies and services
Small Molecules
Biologics
Pharmaceutical Development
Analytical Capabilities
GMP Manufacturing
STARMAP
®
Case Studies
Media Center
Media Center
Press releases
Articles and videos
Company events
Subscribe & contacts
Brochure
Sustainability Ebook
About Nanoform
About Nanoform
Vision, mission and values
Organization
Board of Directors
CEO and Management team
Success stories
Small is green
Our Partners
Investors
Investors
Financial Reports and Presentations
Press releases
Subscribe & contacts
Share and shareholders
Share information
Ownership structure
Share capital development
Analyst Coverage
Notification of major shareholdings
Contact Us
Investor calendar
Certified Adviser
IPO 2020
Corporate Governance
Corporate Governance
Corporate Governance Statements
General Meeting
Annual General Meeting 2025
General meetings
The Board of Directors
Board of Directors
Duties of the Board of Directors
Authorisations
Board committees
Remuneration of the Board
CEO and Management team
Remuneration
Audit
Internal Control and Risk Management
Code of conduct
Articles of Association
Insider administration
Disclosure policy
Transactions of managers
Careers
Contact Us
Investors
Investors
Financial Reports and Presentations
Press releases
Subscribe & contacts
Share and shareholders
Share information
Ownership structure
Share capital development
Analyst Coverage
Notification of major shareholdings
Contact Us
Investor calendar
Certified Adviser
IPO 2020
Corporate Governance
Corporate Governance
Corporate Governance Statements
General Meeting
Annual General Meeting 2025
General meetings
The Board of Directors
Board of Directors
Duties of the Board of Directors
Authorisations
Board committees
Remuneration of the Board
CEO and Management team
Remuneration
Audit
Internal Control and Risk Management
Code of conduct
Articles of Association
Insider administration
Disclosure policy
Transactions of managers
Careers
Contact Us
Investors
Investor calendar
All years
Upcoming events
2026
2025
2024
2023
2022
2021
2020
All years
Financial Calendar
All categories
Financial Calendar
Pharmaceutical events
April 7, 2020
Varsinainen yhtiökokous 2020
April 7, 2020
Årsstämma 2020
April 7, 2020
Annual General Meeting 2020
July 29, 2020
-
August 27, 2020
Hiljainen jakso / Suljettu ikkuna
July 29, 2020
-
August 27, 2020
Silent Period / Closed Window
August 28, 2020, 08:10 EEST
Osavuosikatsaus tammikuu-kesäkuu 2020
August 28, 2020, at 08:10 EEST
Half-year Financial Report for January-June 2020
September 1, 2020
Extraordinary General Meeting 2020
November 17, 2020
-
November 18, 2020
Jefferies Virtual Healthcare Conference, London
November 18, 2020
Nanoform to present at Avanza Börsdag on November 18th
November 25, 2020
Nordea Innovation Seminar, Stockholm
November 27, 2020
Delårsrapport, januari-september 2020
November 27, 2020
Osavuosikatsaus tammikuu-syyskuu 2020
November 27, 2020
Interim Report for January-September 2020
December 9, 2020
Danske Bank Global Teleconference Call to Institutional Investors
December 9, 2020
Danske Bank Maailmanlaajuinen Telekonferenssi Institutionaalisille Sijoittajille
December 9, 2020
Danske Bank Global Telekonferens för Institutionella Investerare
December 12th, 2020 at 21.30 EEST/20.30 CEST
Nanoform is featured on Advancements TV with Ted Danson at business news channel CNBC
12 joulukuu, 2020 kello 21.30 EEST/20.30 CEST
Nanoform mukana Advancement TV ohjelmassa Ted Dansonin kanssa CNBC uutiskanavalla
January 18, 2021
-
January 19, 2021
SEB Healthcare Seminar, Stockholm
February 26, 2021
Bokslutskommuniké 2020
February 26, 2021
Tilinpäätös 2020
February 26, 2021
Annual Review 2020. Financial Statements for financial year 2020
March 16, 2021
-
March 18, 2021
J.P. Morgan Cazenove 10th annual Pan-European Small/Mid-Cap CEO Conference, London (virtual)
April 6, 2021
Annual General Meeting 2021
April 6, 2021
Varsinainen yhtiökokous 2021
April 6, 2021
Årsstämma 2021
May 27, 2021
Delårsrapport, januari-mars 2021
May 27, 2021
Interim Report for January-March 2021
May 27, 2021
Osavuosikatsaus tammikuu-maaliskuu 2021
June 4, 2021
Pääomamarkkinapäivä
June 4, 2021
Capital Markets Day (virtual) – 14.00-16.00 Helsinki time
August 26, 2021
Delårsrapport, januari-juni 2021
August 26, 2021
Osavuosikatsaus tammikuu-kesäkuu 2021
August 26, 2021
Interim Report for January-June 2021
September 13, 2021
Kepler Cheuvreux Autumn Conference
September 13, 2021
Danske Bank Event Series: Life Science
October 18, 2021
-
October 22, 2021
Barclays Capital – US Institutional Roadshow
November 16, 2021
-
November 18, 2021
Jefferies Global Healthcare Conference, London
November 17, 2021
Extraordinary General Meeting 2021
November 17, 2021
Ylimääräinen yhtiökokous 2021
November 18, 2021
-
November 19, 2021
Jefferies Global Healthcare Conference, London
November 25, 2021
Delårsrapport, januari-september 2021
November 25, 2021
Osavuosikatsaus tammikuu-syyskuu 2021
November 25, 2021
Interim Report for January-September 2021
February 22, 2022
Tilinpäätös 2021
February 22, 2022
Annual Review 2021. Financial Statements for financial year 2021
February 22, 2022
Årsredovisning & Bokslutskommuniké 2021
April 12, 2022
Annual General Meeting 2022
April 12, 2022
Årsstämma 2022
May 24, 2022
Interim Report January-March 2022
May 24, 2022
Osavuosikatsaus tammikuu-maaliskuu 2022
May 24, 2022
Delårsrapport, januari-mars 2022
August 25, 2022
Delårsrapport, januari-juni 2022
August 25, 2022
Interim Report January-June 2022
August 25, 2022
Osavuosikatsaus tammikuu-kesäkuu 2022
November 21, 2022
SEB Annual Digital Healthcare Seminar 2022
November 22, 2022
Danske Bank Small & Midcap Seminar, Helsinki (in person)
November 29, 2022
Interim Report January-September 2022
November 29, 2022
Danske Bank, Helsinki – Nanoform Q3 lunch presentation (in-person)
November 29, 2022
Financial Hearings – Nanoform Q3 global webcast presentation 15.00 EEST
November 29, 2022
-
December 1, 2022
Danske Bank Global Digital Roadshow
November 29, 2022
Osavuosikatsaus tammikuu-syyskuu 2022
December 15, 2022
DNB Nordic Healthcare Conference 2022, Oslo (in person)
January 9, 2023
SEB Nordic Seminar 2023, Copenhagen (in person)
January 18, 2023
Nanoform Analyst Day (sell side), Nanoform Headquarter, Helsinki (in person)
February 28, 2023
Annual Review 2022. Financial Statements for financial year 2022
February 28, 2023
Presentation at Kepler Cheuvreux 11.00-12.00 EET (digital)
February 28, 2023
Q4 and FY2022 webcast live presentation at 15.00-16.00 Helsinki time
March 1, 2023
Presentation at SEB, Helsinki (in person)
March 13, 2023
Presentation and 1-1’s at Danske Bank Small & Mid Cap Seminar, Stockholm (in person)
March 14, 2023
Presentation and 1-1’s at Carnegie Nordic Healthcare Seminar, Stockholm (in person)
March 22, 2023
Presentation and 1-1’s at Swedbank Life Science Seminar, Helsinki (in person)
April 12, 2023
Annual General Meeting 2023
April 26, 2023
Factory Tour at Nanoform Headquarter, Helsinki (by invitation only)
May 10, 2023
Factory Tour at Nanoform Headquarter, Helsinki (by invitation only)
May 25, 2023. 3.00 p.m. Finnish time / 2.00 p.m. Swedish time
Q1 Report conference call 2023
May 25, 2023
Interim Report January-March 2023
June 14, 2023
Factory Tour at Nanoform Headquarter, Helsinki (by invitation only)
August 24, 2023
Interim Report January-June 2023
August 24, 2023
Financial Hearings webcast presentation at 15.00 EEST
November 22, 2023
Financial Hearings webcast presentation at 15.00 EET
November 30, 2023
-
November 22, 2023
Interim Report January-September 2023
February 29, 2024
Annual Review 2023. Financial Statements for financial year 2023
April 16, 2024
Annual General Meeting 2024
May 30, 2024
Interim Report January-March 2024
August 29, 2024
Half-year Financial Report January-June 2024
November 18, 2024
Interim Report January-September 2024
February 27, 2025
Annual Review 2024, Financial Statements Review 2024
April 15, 2025
Annual General Meeting 2025
May 20, 2025
Interim Report January-March 2025
August 21, 2025
Interim Report January-June 2025
November 20, 2025
Interim Report January-September 2025
February 26, 2026
Annual Review 2025, Financial Statements Review 2025
Questions from investors, analysts and journalists
Discover more
